Results 171 to 180 of about 8,705 (221)
Macrophage transition to a myofibroblast state drives fibrotic disease in uropathogenic E. coli-induced epididymo-orchitis. [PDF]
J Clin InvestWang M +10 more
europepmc +1 more source
Characterization of TMEM16F-Specific Affibodies and Their Cellular Effects. [PDF]
Membranes (Basel)Kim E, Bang J, Kim S, Lee BC.
europepmc +1 more source
Niclosamide: Beyond an antihelminthic drug
Cellular Signalling, 2018 Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide. However recent studies have indicated that niclosamide may have broad clinical applications for the treatment of diseases other than those caused by parasites.
Richard T Premont, Jiangbo Wang
exaly +3 more sources
Niclosamide ethanolamine inhibits artery constriction
Pharmacological Research, 2017 We previously demonstrated that the typical mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP) inhibited artery constriction, but CCCP was used only as a pharmacological tool. Niclosamide is an anthelmintic drug approved by FDA.
Xin Shen, De-Li Dong
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Aqueous Photolysis of Niclosamide
Journal of Agricultural and Food Chemistry, 2004The photodegradation of [(14)C]niclosamide was studied in sterile, pH 5, 7, and 9 buffered aqueous solutions under artificial sunlight at 25.0 +/- 1.0 degrees C. Photolysis in pH 5 buffer is 4.3 times faster than in pH 9 buffer and 1.5 times faster than in pH 7 buffer. In the dark controls, niclosamide degraded only in the pH 5 buffer.
Phillip W, Graebing +3 more
openaire +2 more sources
2010
Niclosamide is an antihelminthic commercially available in Germany marketed under the trade name of Yomesan by Bayer. It was available until recently in the UK by the same brand name and until approximately 10 years ago in the United States under the brand name Niclocide.
Griffin, Paul M., McCarthy, James
openaire +2 more sources
Niclosamide is an antihelminthic commercially available in Germany marketed under the trade name of Yomesan by Bayer. It was available until recently in the UK by the same brand name and until approximately 10 years ago in the United States under the brand name Niclocide.
Griffin, Paul M., McCarthy, James
openaire +2 more sources